Literature DB >> 29483795

The relationship between paediatric practitioners and 'industry'.

Susan Albersheim1, Kevin Coughlin1.   

Abstract

Paediatric practitioners interact with industry representatives for many purposes but most often to receive information on new and existing products. While practitioners believe they are immune to the marketing influences exerted by these representatives, research has demonstrated otherwise. The literature suggests that the public is aware of such influences and that most people feel industry influence on practitioners is inappropriate. National guidelines go some way toward regulating practitioner-industry interactions, although they are not always clear or sufficient. The present practice point explores the context for these relationships, raises some ethical issues specific to paediatric practitioners and provides recommendations for maintaining professional integrity in the patient-physician relationship. Paediatric practitioners have a professional duty to ensure that their own interactions with industry are conducted with the best interests of the patient front and centre.

Entities:  

Keywords:  Beneficence; COI; Gifting; Non-maleficence

Year:  2017        PMID: 29483795      PMCID: PMC5804756          DOI: 10.1093/pch/pxx096

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  15 in total

1.  A social science perspective on gifts to physicians from industry.

Authors:  Jason Dana; George Loewenstein
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

2.  Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Authors:  Mohit Bhandari; Jason W Busse; Dianne Jackowski; Victor M Montori; Holger Schünemann; Sheila Sprague; Derek Mears; Emil H Schemitsch; Dianne Heels-Ansdell; P J Devereaux
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

3.  All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.

Authors:  Dana Katz; Arthur L Caplan; Jon F Merz
Journal:  Am J Bioeth       Date:  2010-10       Impact factor: 11.229

Review 4.  To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?

Authors:  Aaron E Carroll; Rachel C Vreeman; Jennifer Buddenbaum; Thomas S Inui
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

5.  Pharmaceutical representatives do influence physician behaviour.

Authors:  Gwyn Harris
Journal:  Fam Pract       Date:  2009-06       Impact factor: 2.267

6.  Debunking myths in physician-industry conflicts of interest.

Authors:  Paul R Lichter
Journal:  Am J Ophthalmol       Date:  2008-06-06       Impact factor: 5.258

7.  The devil in the detail(ing).

Authors:  Haavi Morreim
Journal:  Am J Bioeth       Date:  2010-01       Impact factor: 11.229

Review 8.  Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.

Authors:  Philip B Mitchell
Journal:  Med J Aust       Date:  2009-09-07       Impact factor: 7.738

9.  Physician attitudes toward industry: a view across the specialties.

Authors:  Deborah Korenstein; Salomeh Keyhani; Joseph S Ross
Journal:  Arch Surg       Date:  2010-06

10.  Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.

Authors:  D Edwards; A Ballantyne
Journal:  Intern Med J       Date:  2009-03       Impact factor: 2.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.